A new hypothesis for the cancer mechanism

por Meng, Xiaolong, Zhong, Jie, Liu, Shuying, Murray, Mollianne, Gonzalez-Angulo, Ana M.
Publicado 2011

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer

por Sohn, Joohyuk, Liu, Shuying, Parinyanitikul, Napa, Lee, Jangsoon, Hortobagyi, Gabriel N., Mills, Gordon B., Ueno, Naoto T., Gonzalez-Angulo, Ana M.
Publicado 2014

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

por Le Du, Fanny, Eckhardt, Bedrich L., Lim, Bora, Litton, Jennifer K., Moulder, Stacy, Meric-Bernstam, Funda, Gonzalez-Angulo, Ana M., Ueno, Naoto T.
Publicado 2015

Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes

por Chae, Young Kwang, Brown, Erika N., Lei, Xiudong, Melhem-Bertrandt, Amal, Giordano, Sharon H., Litton, Jennifer K., Hortobagyi, Gabriel N., Gonzalez-Angulo, Ana M., Chavez-MacGregor, Mariana
Publicado 2013

Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving ther...

por Caudle, Abigail S, Yu, Tse-Kuan, Tucker, Susan L, Bedrosian, Isabelle, Litton, Jennifer K, Gonzalez-Angulo, Ana M, Hoffman, Karen, Meric-Bernstam, Funda, Hunt, Kelly K, Buchholz, Thomas A, Mittendorf, Elizabeth A
Publicado 2012

Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer

por Liu, Shuying, Meng, Xiaolong, Chen, Huiqin, Liu, Wenbin, Miller, Todd, Murph, Mandi, Lu, Yiling, Zhang, Fan, Gagea, Mihai, Arteaga, Carlos L., Mills, Gordon B., Meric-Bernstam, Funda, González-Angulo, Ana M.
Publicado 2014

P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT, and MEK/ERK signaling in breast cancer

por Dillon, Lloye M., Bean, Jennifer R., Yang, Wei, Shee, Kevin, Symonds, Lynn K., Balko, Justin M., McDonald, W. Hayes, Liu, Shuying, Gonzalez-Angulo, Ana M., Mills, Gordon B., Arteaga, Carlos L., Miller, Todd W.
Publicado 2014

Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling

por Pradeep, Chaluvally-Raghavan, Köstler, Wolfgang J., Lauriola, Mattia, Granit, Roy, Zhang, Fan, Jacob-Hirsch, Jasmine, Rechavi, Gideon, Nair, Hareesh B., Hennessy, Bryan T., Gonzalez-Angulo, Ana M., Tekmal, Rajeshwar R., Ben-Porath, Ittai, Mills, Gordon, Domany, Eytan, Yarden, Yosef
Publicado 2011

Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma

por Krishnamurthy, Savitri, Woodward, Wendy, Yang, Wei, Reuben, James M, Tepperberg, James, Ogura, Dai, Niwa, Shin-ichiro, Huo, Lei, Gong, Yun, El-Zein, Randa, Gonzalez-Angulo, Ana M, Chavez-MacGregor, Mariana, Alvarez, Ricardo, Lucci, Anthony, Valero, Vicente, Ueno, Naoto T
Publicado 2013

Functional consequence of the MET-T1010I polymorphism in breast cancer

por Liu, Shuying, Meric-Bernstam, Funda, Parinyanitikul, Napa, Wang, Bailiang, Eterovic, Agda K., Zheng, Xiaofeng, Gagea, Mihai, Chavez-MacGregor, Mariana, Ueno, Naoto T., Lei, Xiudong, Zhou, Wanding, Nair, Lakshmy, Tripathy, Debu, Brown, Powel H., Hortobagyi, Gabriel N., Chen, Ken, Mendelsohn, John, Mills, Gordon B., Gonzalez-Angulo, Ana M.
Publicado 2014

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer

por Gonzalez-Angulo, Ana M, Hennessy, Bryan T, Meric-Bernstam, Funda, Sahin, Aysegul, Liu, Wenbin, Ju, Zhenlin, Carey, Mark S, Myhre, Simen, Speers, Corey, Deng, Lei, Broaddus, Russell, Lluch, Ana, Aparicio, Sam, Brown, Powel, Pusztai, Lajos, Symmans, W Fraser, Alsner, Jan, Overgaard, Jens, Borresen-Dale, Anne-Lise, Hortobagyi, Gabriel N, Coombes, Kevin R, Mills, Gordon B
Publicado 2011